CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Dyadic International, Inc. - DYAI CFD

1.6394
1.19%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.1512
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.030779%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.013666%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.6202
Open* 1.6192
1-Year Change* -53.34%
Day's Range* 1.6192 - 1.6394
52 wk Range 1.58-4.98
Average Volume (10 days) 42.51K
Average Volume (3 months) 750.02K
Market Cap 49.70M
P/E Ratio -100.00K
Shares Outstanding 28.56M
Revenue 2.50M
EPS -0.42
Dividend (Yield %) N/A
Beta 0.47
Next Earnings Date Mar 27, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 26, 2023 1.6394 0.0202 1.25% 1.6192 1.6394 1.6192
Jan 25, 2023 1.6202 0.0590 3.78% 1.5612 1.6202 1.5612
Jan 24, 2023 1.6104 0.0010 0.06% 1.6094 1.6196 1.5523
Jan 23, 2023 1.5527 0.1155 8.04% 1.4372 1.5625 1.4274
Jan 20, 2023 1.4568 0.0392 2.77% 1.4176 1.4572 1.3890
Jan 19, 2023 1.4186 0.0202 1.44% 1.3984 1.4284 1.3888
Jan 18, 2023 1.4090 -0.1049 -6.93% 1.5139 1.5239 1.3894
Jan 17, 2023 1.5145 -0.0190 -1.24% 1.5335 1.5723 1.4949
Jan 13, 2023 1.5433 0.0871 5.98% 1.4562 1.5531 1.4562
Jan 12, 2023 1.4186 0.0585 4.30% 1.3601 1.4186 1.3601
Jan 11, 2023 1.3803 0.0106 0.77% 1.3697 1.3997 1.3603
Jan 10, 2023 1.3897 0.1253 9.91% 1.2644 1.3994 1.2644
Jan 9, 2023 1.3038 -0.0661 -4.83% 1.3699 1.3899 1.2740
Jan 6, 2023 1.3611 0.0865 6.79% 1.2746 1.3611 1.2746
Jan 5, 2023 1.2652 0.0200 1.61% 1.2452 1.2750 1.2452
Jan 4, 2023 1.3131 0.0104 0.80% 1.3027 1.3517 1.2836
Jan 3, 2023 1.2740 0.0765 6.39% 1.1975 1.3036 1.1975
Dec 30, 2022 1.1789 0.0104 0.89% 1.1685 1.1887 1.1310
Dec 29, 2022 1.1789 0.0200 1.73% 1.1589 1.2077 1.1589
Dec 28, 2022 1.1693 -0.0088 -0.75% 1.1781 1.2171 1.1689

Dyadic International, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 0.59289 0.75842 1.29545 1.68108 1.60192 2.40383
Revenue 0.59289 0.75842 1.29545 1.68108 1.60192 2.40383
Cost of Revenue, Total 0.51616 0.6802 1.02728 1.4597 1.42493 1.94444
Gross Profit 0.07673 0.07822 0.26817 0.22138 0.17699 0.45939
Total Operating Expense 4.44813 3.52708 8.8879 10.9637 11.6276 17.1313
Selling/General/Admin. Expenses, Total 4.56212 5.03035 4.52268 5.51992 6.0848 6.69762
Research & Development 0.8856 2.2031 3.31716 3.95632 3.86812 8.39237
Interest Expense (Income) - Net Operating 0.14734 -0.24906 0.02078 0.02773 0.06235 0.09689
Unusual Expense (Income) -2.1 -4.35822 0
Other Operating Expenses, Total 0.43692 0.22072 0 0.18739 0
Operating Income -3.85524 -2.76866 -7.59245 -9.28259 -10.0257 -14.7275
Interest Income (Expense), Net Non-Operating 0.48458 0.56615 0.89453 0.98493 0.73171 1.65724
Net Income Before Taxes -3.37067 -2.20251 -6.69791 -8.29766 -9.29396 -13.0702
Net Income After Taxes -3.60874 -1.33582 -5.69176 -8.30797 -9.32527 -13.0702
Net Income Before Extra. Items -3.60874 -1.33582 -5.69176 -8.30797 -9.32527 -13.0702
Total Extraordinary Items 0 -0.8
Net Income -3.60874 -2.13582 -5.69176 -8.30797 -9.32527 -13.0702
Income Available to Common Excl. Extra. Items -3.60874 -1.33582 -5.69176 -8.30797 -9.32527 -13.0702
Income Available to Common Incl. Extra. Items -3.60874 -2.13582 -5.69176 -8.30797 -9.32527 -13.0702
Diluted Net Income -3.60874 -2.13582 -5.69176 -8.30797 -9.32527 -13.0702
Diluted Weighted Average Shares 36.5384 28.918 27.6733 27.0037 27.4716 27.8381
Diluted EPS Excluding Extraordinary Items -0.09877 -0.04619 -0.20568 -0.30766 -0.33945 -0.46951
Diluted Normalized EPS -0.13612 -0.14415 -0.20568 -0.30766 -0.33945 -0.46951
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 0.46052 0.93709 0.69293 0.31329 0.64843
Revenue 0.46052 0.93709 0.69293 0.31329 0.64843
Cost of Revenue, Total 0.39076 0.8295 0.39254 0.33163 0.40475
Gross Profit 0.06976 0.10759 0.30039 -0.01834 0.24368
Total Operating Expense 3.78114 4.80417 4.01693 4.52908 3.39306
Selling/General/Admin. Expenses, Total 1.55401 1.74761 1.69284 1.70316 1.6557
Research & Development 1.8081 2.20924 1.90155 2.47348 1.34286
Interest Expense (Income) - Net Operating 0.02827 0.01781 0.03 0.02081 -0.01025
Operating Income -3.32062 -3.86708 -3.324 -4.21579 -2.74463
Interest Income (Expense), Net Non-Operating 0.02567 0.0209 0.0032 1.60746 0.00297
Net Income Before Taxes -3.29495 -3.84617 -1.71527 -4.21386 -2.49167
Net Income After Taxes -3.29495 -3.84617 -1.71527 -4.21386 -2.49167
Net Income Before Extra. Items -3.29495 -3.84617 -1.71527 -4.21386 -2.49167
Net Income -3.29495 -3.84617 -1.71527 -4.21386 -2.49167
Income Available to Common Excl. Extra. Items -3.29495 -3.84617 -1.71527 -4.21386 -2.49167
Income Available to Common Incl. Extra. Items -3.29495 -3.84617 -1.71527 -4.21386 -2.49167
Diluted Net Income -3.29495 -3.84617 -1.71527 -4.21386 -2.49167
Diluted Weighted Average Shares 27.5333 27.6454 28.0792 28.0884 28.2513
Diluted EPS Excluding Extraordinary Items -0.11967 -0.13913 -0.06109 -0.15002 -0.0882
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.11967 -0.13913 -0.06109 -0.15002 -0.0882
Other Operating Expenses, Total 0 0 0
Other, Net 1.60553 -1.60553 0.25
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 57.6279 49.6158 42.7481 35.6392 29.7815 21.0083
Cash and Short Term Investments 48.9394 47.6851 41.2028 34.2227 29.0945 20.2603
Cash & Equivalents 6.88936 5.78635 2.38631 4.82354 20.6371 15.7485
Short Term Investments 42.05 41.8988 38.8164 29.3992 8.45745 4.51178
Total Receivables, Net 1.08137 0.76087 1.11985 1.31244 0.40645 0.37221
Accounts Receivable - Trade, Net 0.58821 0.27103 0.31874 0.55853 0.2942 0.27783
Prepaid Expenses 0.24229 1.1698 0.42545 0.10411 0.28056 0.37583
Other Current Assets, Total 7.36486 0
Total Assets 58.7004 50.7442 43.3008 37.4525 30.0724 21.2991
Long Term Investments 1.06664 0.92265 0 1.51164 0.28471 0.28471
Other Long Term Assets, Total 0.00585 0.20574 0.05214 0.05131 0.00623 0.00612
Total Current Liabilities 1.01024 0.7689 0.84964 1.58803 1.62587 2.55572
Accounts Payable 0.27906 0.52026 0.30906
Accrued Expenses 0.389 0.14796 0.39958 0.566 0.48976 0.70956
Notes Payable/Short Term Debt 0 0 0 0 0 0
Other Current Liabilities, Total 0.34218 0.10068 0.141 1.02202 1.13612 1.84616
Total Liabilities 1.01024 0.7689 0.84964 1.58803 1.62587 2.90866
Total Long Term Debt 0 0 0 0 0 0
Total Equity 57.6902 49.9753 42.4512 35.8645 28.4466 18.3905
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.03893 0.03894 0.03897 0.03961 0.03975 0.04048
Additional Paid-In Capital 93.2575 93.9136 94.3852 96.1059 98.0131 101.026
Retained Earnings (Accumulated Deficit) -25.2043 -27.3514 -33.0431 -41.3511 -50.6763 -63.7466
Treasury Stock - Common -10.4019 -16.6259 -18.9299 -18.9299 -18.9299 -18.9299
Other Equity, Total 0
Total Liabilities & Shareholders’ Equity 58.7004 50.7442 43.3008 37.4525 30.0724 21.2991
Total Common Shares Outstanding 32.3823 28.3278 26.7135 27.3592 27.4942 28.2292
Note Receivable - Long Term 0.50062 0.25031 0
Other Liabilities, Total 0.35294
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 27.9914 26.1564 23.5722 21.0083 16.2413
Cash and Short Term Investments 27.233 25.6007 22.7478 20.2603 15.4401
Cash & Equivalents 13.0556 14.0188 13.6606 15.7485 12.419
Short Term Investments 14.1774 11.5819 9.0872 4.51178 3.02106
Total Receivables, Net 0.54216 0.45475 0.25443 0.37221 0.55705
Accounts Receivable - Trade, Net 0.38496 0.29144 0.17963 0.27783 0.52815
Prepaid Expenses 0.21619 0.10089 0.56997 0.37583 0.24417
Total Assets 28.2822 26.4473 23.8631 21.2991 18.5302
Long Term Investments 0.28471 0.28471 0.28471 0.28471 2.28283
Other Long Term Assets, Total 0.00615 0.00617 0.00614 0.00612 0.0061
Total Current Liabilities 2.59373 3.28849 1.96293 2.55572 1.82648
Accrued Expenses 0.27767 0.5948 0.84245 0.70956 0.53301
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 2.31606 2.69368 1.12048 1.84616 1.29347
Total Liabilities 2.59373 3.28849 1.96293 2.90866 2.1353
Total Long Term Debt 0 0 0 0 0
Total Equity 25.6885 23.1588 21.9001 18.3905 16.3949
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.03981 0.04033 0.04033 0.04048 0.04052
Additional Paid-In Capital 98.5499 99.8658 100.322 101.026 101.523
Retained Earnings (Accumulated Deficit) -53.9713 -57.8175 -59.5327 -63.7466 -66.2383
Treasury Stock - Common -18.9299 -18.9299 -18.9299 -18.9299 -18.9299
Total Liabilities & Shareholders’ Equity 28.2822 26.4473 23.8631 21.2991 18.5302
Total Common Shares Outstanding 27.5542 28.0792 28.0792 28.2292 28.2642
Other Liabilities, Total 0.35294 0.30882
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -3.60874 -2.13582 -5.69176 -8.30797 -9.32527 -13.0702
Cash From Operating Activities -6.03539 -1.69117 -4.40719 -5.78289 -6.57439 -11.2769
Non-Cash Items 0.26522 1.28542 1.16463 1.39701 1.76081 0.60508
Cash Taxes Paid 0.0115 0.16374 0 -0.50687 -0.50062 0
Cash Interest Paid 0.00091
Changes in Working Capital -2.69187 -0.84078 0.11994 1.12806 0.99008 1.18823
Cash From Investing Activities -42.556 -0.81208 3.32832 7.70745 22.122 5.22159
Other Investing Cash Flow Items, Total -42.556 -0.81208 3.32832 7.70745 22.122 5.22159
Cash From Financing Activities -13.1204 -6.22253 -2.29954 0.55019 0.25547 1.23005
Financing Cash Flow Items 0.04063
Issuance (Retirement) of Stock, Net -13.161 -6.22253 -2.29954 0.55019 0.25547 1.23005
Issuance (Retirement) of Debt, Net 0
Net Change in Cash -61.7118 -8.46787 -3.40003 2.43723 15.8135 -4.88857
Foreign Exchange Effects 0.25792 -0.02162 -0.03752 0.01037 -0.06326
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -3.29495 -7.14112 -8.85639 -13.0702 -2.49167
Cash From Operating Activities -1.90651 -4.30778 -8.64188 -11.2769 -2.85038
Non-Cash Items 0.51329 1.07275 0.04914 0.60508 0.45699
Changes in Working Capital 0.87514 1.76059 0.16537 1.18823 -0.81571
Cash From Investing Activities -5.78394 -3.28394 0.72159 5.22159 -0.52085
Other Investing Cash Flow Items, Total -5.78394 -3.28394 0.72159 5.22159 -0.52085
Cash From Financing Activities 0.1158 0.98614 0.98555 1.23005 0.04235
Issuance (Retirement) of Stock, Net 0.1158 0.98614 0.98555 1.23005 0.04235
Foreign Exchange Effects -0.00683 -0.01264 -0.0417 -0.06326 -0.00057
Net Change in Cash -7.58149 -6.61822 -6.97643 -4.88857 -3.32945
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Emalfarb (Mark A) Individual Investor 15.8684 4532493 138478 2023-01-03 LOW
Francisco Trust Corporation 12.4235 3548528 0 2022-04-14 LOW
Bandera Partners LLC Investment Advisor/Hedge Fund 5.4858 1566908 0 2022-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.6382 753551 0 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.8822 251976 996 2022-09-30 LOW
Northeast Financial Consultants Inc Investment Advisor 0.8753 250000 0 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.736 210215 0 2022-09-30 LOW
Tarnok (Michael P) Individual Investor 0.6614 188929 0 2022-04-14 LOW
DIM Funds SICAV S.A. Hedge Fund 0.4796 137000 137000 2021-12-31
Sage Mountain Advisors, LLC Investment Advisor 0.3731 106564 -1816 2022-09-30 MED
Herbst (Seth J. M.D.) Individual Investor 0.3676 105000 50000 2022-04-14 MED
Millennium Management LLC Hedge Fund 0.3525 100674 -50298 2022-09-30 HIGH
Rawson (Ping Wang) Individual Investor 0.2971 84851 39351 2023-01-03 LOW
Hazelton (Joseph P) Individual Investor 0.2011 57448 57448 2023-01-03
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.198 56550 0 2022-09-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.182 51974 1857 2022-09-30 LOW
Pekin Hardy Strauss Wealth Management Investment Advisor 0.1794 51240 0 2022-09-30 LOW
Perkins Capital Management, Inc. Investment Advisor 0.1684 48100 0 2022-12-31 LOW
Forefront Analytics, LLC Investment Advisor/Hedge Fund 0.142 40546 -6225 2022-09-30 LOW
Kaye (Jack) Individual Investor 0.1385 39557 -33150 2022-11-21 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
+485000+

Traders

65000+

Active clients monthly

$48000000+

Monthly investing volume

$28000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Dyadic International, Inc. Company profile

About Dyadic International, Inc.

Dyadic International, Inc. is a biotechnology platform company. The Company is focused on developing C1 platform for use in human and animal pharmaceutical applications across the world. The C1 platform technology is based on the Myceliopthora thermophila fungus, which the Company named it as C1. The C1 gene expression platform is used in the discovery, development and manufacturing of biologic medicines and vaccines. The C1 technology is a fungal expression system for gene discovery, development, and production of enzymes and other proteins. The C1 technology is commercially available solutions to uptake genes and develop industrial processes to produce volumes of enzymes and other protein products. The Company is also working on COVID-19 related vaccine and antibody opportunities, including COVID-19 vaccine candidate, DYAI-100.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Dyadic International, Inc. revenues increased 66% to $2.1M. Net loss increased 20% to $8.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and Development - Balancing val increase from $2M to $5.8M (expense), General and administration increase of 61% to $3.8M (expense).

Equity composition

Common Stock $.001 Par, 12/10, 100M auth., 31,138,120 issd. insiders own 6.80%.10/29/04, acquired CCP Worldwide Inc. as a reverse acquisition.01/08, Company delisted from AMEX to OTC Pink Sheets.

Industry: Biotechnology & Medical Research (NEC)

140 Intracoastal Pointe Dr Ste 404
JUPITER
FLORIDA 33477
US

Income Statement

  • Annual
  • Quarterly

People also watch

US100

11,990.00 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0179%
Short position overnight fee 0.0070%
Overnight fee time 22:00 (UTC)
Spread 1.8

ETH/USD

1,580.94 Price
-1.620% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 5.00

XRP/USD

0.41 Price
-1.180% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00336

BTC/USD

22,998.20 Price
-0.540% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 60.00

Still looking for a broker you can trust?

Join the 480.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading